Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
10/12/2011 | EP2373632A1 Substituted benzyl and phenylsulfonyl triazolones, and use thereof |
10/12/2011 | EP2373339A1 A b cell depleting agent for the treatment of atherosclerosis |
10/12/2011 | EP2373328A2 Stroke-generated angiogenesis enhancers and uses thereof |
10/12/2011 | EP2373317A1 Soluble guanylate cyclase activators |
10/12/2011 | EP2373306A1 Transdermally administered aliskiren |
10/12/2011 | EP2176253B1 A process for the preparation or purification of olmesartan medoxomil or olmesartan medoxomil hydrohalide salt |
10/12/2011 | EP2051991B1 Cardioprotective compounds |
10/12/2011 | EP2004173B1 Use of aminapthone for the preparation of a medicament for treating arteriophaties |
10/12/2011 | EP1853266B1 2s,4r ketoconazole for treating diabetes, metabolic syndrome and other conditions |
10/12/2011 | EP1761522B1 Compounds and methods for treating dyslipidemia |
10/12/2011 | EP1385820B1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
10/12/2011 | EP1366022B1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
10/12/2011 | CN1981803B Chinese-medicinal composition for preventing cardiovascular diseases and its production |
10/12/2011 | CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
10/12/2011 | CN102216318A Antioxidant |
10/12/2011 | CN102216317A Antioxidant |
10/12/2011 | CN102216316A Substituted amine derivative and medicinal composition comprising same as the active ingredient |
10/12/2011 | CN102216305A Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes |
10/12/2011 | CN102216304A Alkylcyclohexylethers of dihydrotetraazabenzoazulenes |
10/12/2011 | CN102216268A Novel estrogen receptor ligands |
10/12/2011 | CN102215857A Pharmaceutical composition containing ginger extract or shogaol |
10/12/2011 | CN102215845A Solid state forms of a pharmaceutical |
10/12/2011 | CN102212557A Recombinant vector for preparing medicament for treating atherosclerosis and recombinant cell |
10/12/2011 | CN102212140A Preparation of VEGF165 (vascular endothelial growth factor 165) analogue |
10/12/2011 | CN102212093A Flavonoid glycoside compounds, method for preparing same and application |
10/12/2011 | CN102212091A High-purity geniposide as well as preparation and clinical application of preparations thereof |
10/12/2011 | CN102212069A Cycloalkane derivative, preparation method thereof and application thereof in medicaments for cardiovascular and cerebrovascular diseases |
10/12/2011 | CN102212068A Thiofuran derivative, preparation method thereof and application thereof in medicaments |
10/12/2011 | CN102212062A Derivative of amino ester, salt thereof and using method |
10/12/2011 | CN102212021A Sodium paeonol sulfonate crystalline hydrate, and preparation method and application thereof |
10/12/2011 | CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof |
10/12/2011 | CN102212001A Compound salvianolic acid F methyl ester and preparation method thereof |
10/12/2011 | CN102210839A Traditional Chinese medicine capsule for treating coronary heart disease |
10/12/2011 | CN102210835A Traditional Chinese medicine for treating coronary disease |
10/12/2011 | CN102210815A Chinese medicine composition with functions of improving myocardial ischemia and blood viscosity and preparation method thereof |
10/12/2011 | CN102210807A Application of traditional Chinese medicine composition in preparation of medicaments for treating angina pectoris |
10/12/2011 | CN102210806A Application of Chinese medicinal composition to preparation of medicaments for treating nonorganic heart disease arrhythmia |
10/12/2011 | CN102210799A Medicament for treating peripheral vascular disease |
10/12/2011 | CN102210792A Traditional Chinese medicine for preventing and treating deep venous thrombosis |
10/12/2011 | CN102210779A Application of lycium barbarum polysaccharide-III (LBP-III) in preparation of medicaments for preventing and treating vascular injury caused by organophosphorus pesticides |
10/12/2011 | CN102210775A Chinese medicine for treating hemorrhoids, preparation method thereof and using method thereof |
10/12/2011 | CN102210767A Traditional Chinese medicine for treating hypertension |
10/12/2011 | CN102210764A Application of sweet almond oil in preparing medicament for treating myocardial ischemia reperfusion injury |
10/12/2011 | CN102210763A Chinese medicinal composition for promoting blood circulation, removing blood stasis, promoting qi circulation and relieving pain and preparation method thereof |
10/12/2011 | CN102210762A Application of Chinese medicine composition in preparation of medicine for preventing nonvalvular atrial fibrillation thrombo-embolism |
10/12/2011 | CN102210761A Application of Chinese medicinal component in preparation of medicament for treating chronic mesenteric ischemia |
10/12/2011 | CN102210759A Application of Chinese medicinal component in preparation of nitric oxide donor medicament |
10/12/2011 | CN102210757A Application of Chinese medicine composition in preparation of medicine for treating coronary heart disease malignant arrhythmia |
10/12/2011 | CN102210745A Medicinal liquor and preparation method thereof |
10/12/2011 | CN102210743A Formula of medicament for treating angina pectoris of coronary disease and preparation method of medicament for treating angina pectoris of coronary disease |
10/12/2011 | CN102210739A Method for extracting total saponins and total flavonoids from alfalfa and preparation method thereof |
10/12/2011 | CN102210732A Method for extracting panax notoginseng saponins from fresh panax notoginseng by enzyme treatment |
10/12/2011 | CN102210731A Soft capsule containing notoginseng adventitious root extract |
10/12/2011 | CN102210730A Medicinal composition containing pseudo-ginseng adventitious root extract |
10/12/2011 | CN102210726A Method for combined extraction of mallow flavones and mallow saponins in seashore mallow and application |
10/12/2011 | CN102210724A Comprehensive use of ovateleaf holly bark medicinal material |
10/12/2011 | CN102210717A Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains |
10/12/2011 | CN102210699A Use of chitosan oligosaccharide in preparation of medicines for preventing and treating cardiovascular and cerebrovascular diseases |
10/12/2011 | CN102210695A Application of creatine phosphate sodium in preparing antishock medicament |
10/12/2011 | CN102210672A Application of polyketide in preparation of angiogenesis inhibiting medicine |
10/12/2011 | CN102210666A Medical use of salvianolic acid A |
10/12/2011 | CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes |
10/12/2011 | CN102210662A Application of lutein in preparation of medicaments for preventing and treating cerebral vascular diseases |
10/12/2011 | CN102210653A Burdock aglycone microemulsion |
10/12/2011 | CN102210535A Neck soothing healing device |
10/12/2011 | CN101972446B Medicament for treating coronary disease and preparation method thereof |
10/12/2011 | CN101972399B Medicament for treating hypertension and preparation method thereof |
10/12/2011 | CN101947303B Drug for radical treatment of hypertension and preparation method thereof |
10/12/2011 | CN101850093B Medicinal composition for treating hyperplasia of mammary glands |
10/12/2011 | CN101829263B Traditional Chinese medicinal composition for treating redness and preparation thereof |
10/12/2011 | CN101766611B Medical composition of levamlodipine or pharmaceutically acceptable salt thereof and beta-blocker and application thereof |
10/12/2011 | CN101717384B Compound in salvia miltiorrhiza bungered sage root injection and application thereof in curing treating cardiovascular disease |
10/12/2011 | CN101524473B Worm grass anticancer longevity pellet and preparation method thereof |
10/12/2011 | CN101428050B Active composition for treating thrombus, cardio-cerebrovascular system diseases |
10/12/2011 | CN101396358B Oxiracetam injection |
10/12/2011 | CN101306169B Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease |
10/12/2011 | CN101264158B Application of Chinese medicine composing prescription in preparing medicaments for treating metabolic syndrome |
10/12/2011 | CN101199847B Drug compound for AT1 receptor antagonist/diuretic/folate coupling and uses thereof |
10/12/2011 | CN101160139B Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing PEDF and FGF2 |
10/11/2011 | US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
10/11/2011 | US8034818 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates |
10/11/2011 | US8034804 (Pyrido/thieno)-[f]-oxazepine-5-one derivatives |
10/11/2011 | US8034799 Preventing and/or treating cardiovascular disease and/or associated heart failure |
10/11/2011 | US8034772 Inhibitor of vascular endothelial cell growth factor |
10/11/2011 | US8034379 Hydrophilic gel foaming matrix; cellulose ethers |
10/11/2011 | CA2673957C Oil-and-fat composition, and food or beverage containing the oil-and-fat composition |
10/11/2011 | CA2494100C Pyrazole compositions useful as inhibitors of gsk-3 |
10/11/2011 | CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases |
10/11/2011 | CA2476405C Compositions and methods for treatment of microbial infections |
10/11/2011 | CA2472479C Deazapurines and uses thereof |
10/11/2011 | CA2457840C Hdl for the treatment of stroke and other ischemic conditions |
10/11/2011 | CA2457054C Activator of peroxisome proliferator-activated receptor .delta. |
10/11/2011 | CA2454665C Modifying the fatty acid composition of cell membranes of organs and tissues |
10/11/2011 | CA2442151C Stable solution of reduced coenzyme q |
10/11/2011 | CA2429674C Generation of therapeutic microfoam |
10/11/2011 | CA2416475C Medicinal uses of mu-opioid receptor agonists |
10/11/2011 | CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
10/11/2011 | CA2393410C Phosphonate compounds |
10/11/2011 | CA2325442C Treatment of cardiac hypertrophy using interferon-gamma |
10/11/2011 | CA2247275C Use of rapamycin derivatives in vasculopathies and xenotransplantation |